Share chart Poseida Therapeutics, Inc.
Extended chart
Simple chart
About Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc., биофармацевтическая компания, работающая на клинической стадии, специализируется на разработке терапевтических средств для пациентов с высокими неудовлетворенными медицинскими потребностями. Компания разрабатывает линейку решений для лечения гематологических злокачественных новообразований и солидных опухолей, а также программы vivo для лечения редких заболеваний, направленных на печень. Кроме того, он предлагает терапию CAR-T для лечения рака. more details| IPO date | 2020-07-10 |
|---|---|
| ISIN | US73730P1084 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | http://www.poseida.com |
| Цена ао | 9.5 |
| Change price per day: | 0% (9.5) |
|---|---|
| Change price per week: | 0% (9.5) |
| Change price per month: | 0% (9.5) |
| Change price per 3 month: | 0% (9.5) |
| Change price per half year: | +283.06% (2.48) |
| Change price per year: | +346.01% (2.13) |
| Change price per 3 year: | +375% (2) |
| Change price per year to date: | -1.04% (9.6) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| FMR, LLC | 14343665 | 14.87 |
| Pentwater Capital Management LP | 5975000 | 6.19 |
| Blackrock Inc. | 5031173 | 5.21 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 3705779 | 3.84 |
| Vanguard Group Inc | 2899319 | 3 |
| Geode Capital Management, LLC | 1523055 | 1.58 |
| State Street Corporation | 1379519 | 1.43 |
| Aisling Capital Management LP | 1043267 | 1.08 |
| Blair (William) & Company, L.L.C. | 682742 | 0.71 |
| Millennium Management LLC | 592578 | 0.61 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Ms. Johanna M. Mylet CPA | Chief Financial Officer | N/A | 1988 (37 years) |
| Ms. Kristin Martin | Chief People & Administration Officer | N/A | |
| Mr. Mark J. Gergen J.D. | Executive Chairman of the Board | 920.74k | 1963 (62 years) |
| Dr. Devon J. Shedlock Ph.D. | Chief Scientific Officer of Cell Therapy | N/A | |
| Ms. Lisa Portale | Senior Vice President of Regulatory Affairs | N/A | |
| Mr. Harry J. Leonhardt Esq., J.D. | General Counsel, Chief Compliance Officer & Corporate Secretary | 630.23k | 1957 (68 years) |
| Mr. Loren Wagner | Chief Operations Officer | N/A | |
| Dr. Kristin Yarema Ph.D. | President, CEO & Director | N/A | 1971 (54 years) |
| Mr. Alexander Chapman | Senior VP of Investor Relations & Corporate Communications | N/A | |
| Dr. Jeffrey W. Winkelman J.D., Ph.D. | Senior VP & Chief Patent Counsel |
Address: United States, San Diego, 9390 Towne Centre Drive - open in Google maps, open in Yandex maps
Website: http://www.poseida.com
Website: http://www.poseida.com
